Type of Study:
Adults 18 years and older with Type 1 or 2 Diabetes and Gastroparesis
18 years and older, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis.